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is the proliferative response of one individual's lymphocytes cultured in the presence of another individual's lymphocytes. In man, the MLR is elicited by cell surface antigenis coded for by the HLA-D gene locus.
This locus is amiiong a cluster of genes which are located on the sixth chromosome and which include genes coding for the major histocompatibility antigens HLA-A, B, and C as well as HLA-D. Ifthe stimulator cell possesses D locus antigenis not present in the responder, the lymphocytes of the latter will undergo blast transformation resulting in DNA synthesis which can be measured. A 
INTRODUCTION
In all species studied, stimulation in the mixed lymphocyte reactioin (MLR)' is controlled primarily by genes in the major histocompatibility coimiplex, a cluster of genes which has been demonstrated to influence several functions of'the immune system (1) (2) (3) . In main, this gene complex termed human leukocyte antigen (HLA) is located on the sixth chromosome and includes genes determining the structure of the serologically defined transplantation antigens, HLA-A, B, and C, as well as the HLA-D anitigens which elicit the MLR (4) .
Unlike the serologically defined antigens, D locus antigens can, at present, be recognized only by the "One-WaY" MLR. In this test, lymphocytes from one individual (the responder) are cultured with x-irradiated or mitomycin C-treated lymphocytes of the second individual (the stimulator). If the stimulator possesses D locus antigens not present in the responder, the lymphocytes of the latter will undergo l)last transformationi, resulting in DNA synthesis which can be measured by incorporation of [3H-]thymidine.
X-irradiation or miitomycin C treatment prevents stimulator cells from undergoing transformation. Cells from one individual will not respond in the MLR to cells from an individtual sharing his MLR (D locus) type, either as an identical heterozygote, or if homozygouis for one of the responder's two D locus types. With this test, it is possible to type for D locus specificities.
In our studies of HLA-D, two persons repeatedly failed to respond in the MLR to one or more x-irradiated allogeneic cells. One of these individuals, a multiparous woman, responded to most allogeneic cells but not to her husband's, and when her thymus-derived (T) cells were added to the responder lymphocytes of HLA identical persons, their responses to her husband's cells were suppressed (5) . The responses of HLA nonidentical persons were not suppressed. Because identity at the D locus was required between suppressor and responder to avoid allogeneic interaction, persons heterozygous for the suppressor's haplotype could not be evaluated reliably for suppressibility. Also, it was not possible to map the genes controlling suppression because in our panel of HLA-B, D homozygous donors identity at the D locus was always accompanied by identity at the serologically defined B locus between suppressor and suppressed cells.
We now report studies of a second individual whose lymphocytes failed to respond in the one-way MLR, and whose T Laboratories, Evanston, Ill.) gradient centrifugation, washed and then resuspended at 1 x 106 cells/ml in RPMI 1640 medium (Grand Island Biological Co., Grand Island, N. Y.) containing 100 U/ml penicillin, 100 ,ug/ml streptomycin, 2mM glutamine, and 10% pooled human type A serum. Stimulating cells were irradiated in a 137Cs irradiator (Mark I model 24 irradiator, J. L. Shepherd, Glendale, Calif.) with a dose of6,000 rads to abolish their capacity to proliferate and to make the reaction unidirectional. Mixed lymphocyte cultures were carried out in round-bottomed microtiter trays (Linbro Chemical Co., Hamden, Conn.) with 50,000 responder cells and 50,000 irradiated stimulators in a volume of 0.15 ml. In three-way cultures, 50,000 suppressor cells were co-cultured with 50,000 responder cells and 50,000 irradiated stimulator cells in 0. 15 (8) . In the first method, 2 ml of Cohn fraction II immunoglobulin (2 mg/ml; Mann Research Laboratories, Inc., New York) and watersoluble dicarbodiimide (1 mg/ml) in phosphate-buffered saline were incubated in a plastic tissue flask (Falcon Plastics, Div. of BioQuest, Oxnard, Caif.) for 1 h at room temperature. After the flask was washed with PBS-5% FCS, 2 ml of a 1:20 dilution of rabbit anti-human immunoglobulin was added and incubated for 30 min at room temperature. Cell mediated antibody-dependent lIympholysis. The method described by Kovithavongs et al. (9) was used. 5 x 106 target lymphocytes in 0.1 ml RPMNI 1640-10% FCS were labeled by incubating with lOO ,uCi 51Cr (New England Nuclear) for 1 h at 37°C with shaking. 2 x 106 effector cells in 1 ml RPMI 1640-10% FCS were added to 0.01 ml (100,000) labeled target cells in triplicate. 0.1 ml of normiial human serum "antibody" was then added and the mixture incubated for 4 h at 37°C. The cells were centrifugedl to a pellet, and the 51Cr released into the supernate counted in a gamma cotunter. Variability between triplicate samples never exceede(d 10% and averaged 5%. The percentage of 51Cr released for each combination was derived by dividing the observed release minus background release (target cell incubated alone) by the maximum available for release (by hypotonic rupture) minus background. Maximal 51Cr release by hypotonic lysis of target cells varied from 75 to 85%.
Stimulatiotn with mitogetns. Stimulation with Coneanavalin A (Coni A, Pharmacia Fine Chemnicals), or phytohemagglutinin (PHA, The Wellcome Foundation, Ltd., The Wellcome Research Laboratories, Beckenham, Kent, England) was carried out in air/5% CO2 for 4 days at 37°C. 100,000 peripheral blood mononuclear leukocytes were incul)ated in round-bottomed microtiter wells (Grand Island Biological) in 0.2 ml of RPM 1 1640-10% pooled human A serum and either 1 ,g Con A or 1 ,ug PHA. Assays were performed in triplicate.
[3H]thymidine 1 ,uCi/well, was added 18 h before harvesting.
Stimulation with soluble anitigens. Stimulation with tetanus toxoid (alum adsorbed, Wyeth, final dilution 1:20,000) and diphtheria toxoid (aluml adsorbed, Sclavo, final dilution 1:2,000) was carried ouit in air/5% CO2 for 7 days at 37°C. 100,000 or 200,000 Ficoll-Hypa(que enriched peripheral blood nollonwticlear cells were incubated with these anitigensi in flatbottomed microtiter wells (Cooke Laboratory Products Div.
Dynatech Laboratories, Inc., Alexandria, Va.). Assays were performed in sextuplicate.
[3H]thymidine (1 ,uCi/well) was added 18 h before harvesting. In two-cell cultures, 100,000 cells fromii each of two donors were co-cultured in the presence of the same concentrationis of the above antigenis.
RESULTS
Shortly after birth the propositus, M. M., was treated with thymic irradiation for "failure to thrive". At 5 wk and again at 6-wk old, he received 128 rads in 1.5 min to a 10 x 10-cm field in the anterior mediastinum (targetskin distance of 50 cm). M. M.'s childhood development was entirely normal, and at the time ofthis report, he is a healthy 23-yr-old caucasian male. None of M. M.'s eight siblings or his parents received thymic irradiation, and their medical histories are unremarkable.
MLR in the facmily M. The HLA types of the members of family M are shown in Table I . M. M., his HLA identical sibling, B. M., and their mother, L. M., are homozygous for HLA-B12. In the MLR, responises of <10,000 epi or relative responses of <30% are considered to be nonstimulatory in this laboratory. By these criteria, the latter three cells stimutlate none ofthe other fuamil members in the MLR, a(nd have been A/B W. M.
35.2(53%)
A/A NL. NM.
The upper part of the shown by cross-testing with reference homozygous typing cells (10) 
it is possible that the apparent suppression at day 7 might in fact be the descending curve of an earlier peak. A time-course experiment was, therefore, carried out to exclude this possibility. Replicate ctultures were set up on day 0 and harvested on days 3-9. The results (Fig. 2) show that in the three-cell mixtujres suppression was maximal at day 7. The patterni of suppression is similar to that observed in another human MLR suppressor system (5) in that proliferation occurs unaffected until days 4-5 at which time the level of [3H]thymidine incorporation begins to decline.
Evidetnce that the suppressor is a T cell. T Table V . It is apparent from both tables that only those responders homozygous or heterozygous for HLA-Dw4 were suppressed regardless of the associated HLA-A, B, or C Controls (105) rainge (20, 019) range (6, 212) Each row describes a 7-day culture between 100,000 or 200,000 responder cells and either tetanus or diphtheria toxoid (see 'Methods for antigen doses). The response in counts per minute+SE represents the mean of six experiments. When NI. M. lymphocytes were irradiated with 6,000 rads (NI. NM.X1 000) anid testedl on the saime panel of responder cells, there was n1o suippressioni (Table VI) . Ofadded significance is the fact that the NILR respoinses of non-Dw4 cells were in general, no greater in the presence of M. . X6,000 thain M. M.x, o, confirming that non-Dw4 cells are not suppressed by XI. N.,1,000. Table VII . M. M. responded only weakly to the great majority of these cells. When L. M. was tested as a responder to these same cells (Table VII) HLA-D Specific Suppressor T Cell 835 The M. M. suppressor T cell is similar to an MLR suppressor T cell described by Rich and Rich (12, 13) in the mouse, in that it lacks specificity for the stimulating haplotvpe but is highly specific for the responder cell. In the murine system, a factor released by MILR suippressor cells only inhibits the response of' cells slharinig the same I-C subregion within the immune response region of the mouse major histocompatibility comiiplex (H-2). In the case of M. MI., the restriction appears to be localized to or near the HLA-D locus. In the absence of an available family with a crossover between HLA-B and HLA-Dw4, localization to the HLA-D end of HLA must remaini tentative. Nonetheless, onl the basis of currenit data it is inferred that genes in the HLA-D region code for structures, presumably on T cells, which are recognized by MILR suppressor T cells as well as for determinants primarily on B cells (the so-called la antigens) which are recognized by NILR responder cells (14, 4) . In the mouse, genes responsible for similar functions have been mapped to the immune responise region in the major histocompatibility complex (12, 15, 16) , a region which influences a remarkable array of immunologic functions (17) . An immune response region is widely presumed to exist in man (18) (19) (20) and although proof of such a region's existence is lacking, the current data are consistent with the hypothesis that HLA-D may be the immune response region in man.
The fact that M. M. is the only member of his family to have received thymic irradiation may suggest that this treatment and M. M.'s MLR suppressor T cell phenomenon are causally related. In this regard, aI)imal studies have demonstrated that the thymus is extremely radiosensitive (21) . Furthermore, recovery from thymic irradiation has been associated with a diminished capacity to reject skin grafts or produce antibody against T cell-dependent antigens, despite normal numbers of peripheral lymphocytes (22) . In man, irradiation of the thymus was once used to treat coniditions such as neonatal respiratory distress that were inappropriately attributed to alleged thymic enlargement. This form of treatment was abandoned in the 1950's after an increased incidence of thyroid caincer was first noted to follow x-irradiation to the neck and mediastinum (23) . Adverse effects of such treatment on the immune system have been reported to include chromosomal aberrations in peripheral blood lymphocytes (24) , a reduction of B and T lymphocytes, and a decreased mitogenic response of lymphocytes to mitogens in such patients as compared with controls (25) . However, such changes were not found in another reported series (26) . Clearly, N. M. retained considerable thymic function after his radiation treatment becauise his lymphocytes proliferate vigorously to the mitogens PHA and Con A as well as to tetanus toxoid, and he has only slightly depressed levels of T cells and B cells in his peripheral blood. Therefore, a definitive conclusioni regarding the role of thymic irradiation in the case of MI. NI. must await a searchl for suppressor cells in other patients who received suclh treatmiienit.
Although only HLA-Dw4 responider-cells were inhibited by the NI. NI. suppressor T cell, Dwv4 cells were inhibited in their responises to all stimuitilator cells tested, regardless of the stimuitilator's HLA type. This result is conisistenit with the possibility that NI. NI. has been sensitized to an anitigeni whiclh either cross-reacts with or is common to a great many cells. Alternatively, NI. NI. may have been senisitized to his owni cells, resulting in suppressor cells directed againist lhis owin HLA-Dw4 products. This hypothesis is supported by the observation that NI. I.'s relatively high autologous response is inhibited by the addition of NI. NI.Xl,0)0 suppressor cells. Furthermore, NI. NI. has no history of exposure to allogeneic cells, to which a specific immune response might be expected. In contrast, a recently reported stimulator-specific NILR suippressor cell arose in a mother of 10 who specifically stuppresse(d responses of HLA identical persons to her husband's cells, presumably as a restult of repeated immuinizationl with cells bearing his HLA antigens during pregnancy (5 
